OUR Archive is not currently accepting deposits due to the upcoming migration to a new system. The new OUR Archive system will be open for deposits on 1 May.
Search
Now showing items 1-2 of 2
Lack of evidence and consequential harm caused by mydriatic regimens used in retinopathy of prematurity screening.
Approximately 3,500 infants in New Zealand and Australia are screened annually for retinopathy of prematurity (ROP). To view the retina and diagnose ROP, adequate pupil dilation with mydriatic medicines is required. ...
I can see clearly now: Survey results from neonatal staff on mydriatic use in retinopathy or prematurity screening
Aims:
Very preterm infants require mydriatic eye drops in preparation for retinopathy of prematurity examination. Mydriatic dosing needs to provide adequate pupil dilation for the examination and yet, avoid adverse ...